Recurrence prevention after venous thromboembolism: Apixaban beats rivaroxaban

被引：0
|
作者：
Ruchalla, Elke
机构：
来源：
PHLEBOLOGIE | 2025年 / 54卷 / 02期
关键词：
D O I：
10.1055/a-2479-8820
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：54 / 56
页数：3
相关论文
共 50 条
  • [41] Apixaban to prevent venous thromboembolism after knee replacement
    Fareed, Jawed
    Hull, Russell
    LANCET, 2010, 375 (9717): : 779 - 780
  • [42] COST-EFFECTIVENESS ANALYSIS OF APIXABAN AND RIVAROXABAN FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN CHINA
    Gu, X.
    Wu, B.
    VALUE IN HEALTH, 2017, 20 (09) : A618 - A618
  • [43] Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight
    Wysokinski, Waldemar E.
    Froehling, David A.
    Houghton, Damon E.
    McBane, Robert D.
    Vlazny, Danielle T.
    Bott-Kitslaar, Dalene M.
    Kuczmik, Wiktoria
    Sutkowska, Karolina
    Bator, Kaja
    Hodge, David O.
    Peterson, Lisa G.
    Casanegra, Ana, I
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (04) : 484 - 494
  • [44] Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study
    Sindet-Pedersen, C.
    Staerk, L.
    Pallisgaard, J. Langtved
    Gerds, T. Alexander
    Berger, J. S.
    Torp-Pedersen, C.
    Gislason, G.
    Olesen, J. Bjerring
    EUROPEAN HEART JOURNAL, 2017, 38 : 1035 - 1035
  • [45] Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes
    Ballerie, Alice
    Van, Remi Nguyen
    Lacut, Karine
    Galinat, Hubert
    Rousseau, Chloe
    Pontis, Adeline
    Nedelec-Gac, Fabienne
    Lescoat, Alain
    Belhomme, Nicolas
    Gueret, Pierre
    Mahe, Guillaume
    Couturaud, Francis
    Jego, Patrick
    Gouin-Thibault, Isabelle
    THROMBOSIS RESEARCH, 2021, 208 : 39 - 44
  • [46] Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban
    Bauersachs, Rupert
    Khorana, Alok A.
    Lee, Agnes Y. Y.
    Soff, Gerald
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 532 - 549
  • [47] Rivaroxaban in the Treatment of Venous Thromboembolism and the Prevention of Recurrences: A Practical Approach
    Arcelus, Juan I.
    Domenech, Pere
    del Carmen Fernandez-Capitan, Ma
    Guijarro, Ricardo
    Jimenez, David
    Jimenez, Sonia
    Lozano, Francisco S.
    Monreal, Manel
    Nieto, Jose A.
    Paramo, Jose A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (04) : 297 - 308
  • [48] Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism
    Crowther, Mark A.
    Cuker, Adam
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (13): : 1279 - 1280
  • [49] COMPARISON OF APIXABAN, DABIGATRAN, RIVAROXABAN, AND EDOXABAN IN THE ACUTE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Cohen, A. T.
    Batson, S.
    Hamilton, M.
    Masseria, C.
    Mitchell, S.
    Phatak, H.
    VALUE IN HEALTH, 2015, 18 (03) : A132 - A132
  • [50] Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China
    Xiaoyu Yan
    Xiaohua Gu
    Lei Zhou
    Houweng Lin
    Bin Wu
    Clinical Drug Investigation, 2016, 36 : 1001 - 1010
12345